A study investigating safety and efficacy of sitagliptin in acute myocardial infarction patients with diabetes and chronic kidney disease.
Phase of Trial: Phase IV
Latest Information Update: 10 Feb 2016
At a glance
- Drugs Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- 10 Feb 2016 New trial record